H.R. 9599 119th Congress
SECURE 340B Act
- Health
- Sponsor: Rep. Peters, Scott H. [D-CA-50]
- Congress.gov ↗
Latest action, Jul 6, 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
8 cosponsors
Sponsored by Rep. Peters, Scott H. [D-CA-50] (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Referred to: House: Education and Workforce Committee; House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
All 25 of 45 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| 340B HEALTH | 2 | $570K | Q2 2026 | Q3 2026 | yes | |
| ASTRAZENECA PHARMACEUTICALS LP | 2 | $2.5M | Q2 2026 | Q3 2026 | yes | |
| BROWN UNIVERSITY HEALTH (FKA LIFESPAN) | 2 | $0 | Q2 2026 | Q3 2026 | yes | |
| CHRONIC CARE POLICY ALLIANCE | 2 | $0 | Q2 2026 | Q3 2026 | yes | |
| NATIONWIDE CHILDREN'S HOSPITAL INC | 2 | $137K | Q2 2026 | Q3 2026 | yes | |
| NOVARTIS | 2 | $2.3M | Q2 2026 | Q3 2026 | yes | |
| PLANNED PARENTHOOD FEDERATION OF AMERICA INC | 2 | $962K | Q2 2026 | Q3 2026 | yes | |
| THE HEMOPHILIA ALLIANCE | ARTEMIS POLICY GROUP LLC | 2 | $60K | Q2 2026 | Q3 2026 | yes |
| UNIVERSITY OF ROCHESTER | 2 | $310K | Q2 2026 | Q3 2026 | yes | |
| ADVOCATES FOR COMMUNITY HEALTH | 1 | $65K | Q3 2026 | Q3 2026 | yes | |
| AMERICA'S ESSENTIAL HOSPITALS | 1 | $470K | Q3 2026 | Q3 2026 | yes | |
| AMERICAN HOSPITAL ASSOCIATION | 1 | $3.8M | Q3 2026 | Q3 2026 | yes | |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 1 | $250K | Q3 2026 | Q3 2026 | yes | |
| AMGEN INC | 1 | $3.1M | Q3 2026 | Q3 2026 | yes | |
| ASCENSION HEALTH ALLIANCE | MEHLMAN CONSULTING, INC. | 1 | $80K | Q3 2026 | Q3 2026 | yes |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 1 | $431K | Q3 2026 | Q3 2026 | yes | |
| ASTRAZENECA PHARMACEUTICALS LP | TODD STRATEGY GROUP | 1 | $0 | Q3 2026 | Q3 2026 | yes |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | 1 | $2.6M | Q3 2026 | Q3 2026 | yes | |
| BOSTON MEDICAL CENTER | RED+BLUE STRATEGIES | 1 | $60K | Q3 2026 | Q3 2026 | yes |
| CENTER FOR INDIVIDUAL FREEDOM | 1 | $20K | Q3 2026 | Q3 2026 | yes | |
| CHILDREN'S HEALTHCARE OF ATLANTA | ARENTFOX SCHIFF LLP | 1 | $0 | Q3 2026 | Q3 2026 | yes |
| EISAI INC. | 1 | $450K | Q3 2026 | Q3 2026 | yes | |
| EMD SERONO INC | 1 | $730K | Q3 2026 | Q3 2026 | yes | |
| GENENTECH | THE MCMANUS GROUP | 1 | $0 | Q3 2026 | Q3 2026 | yes |
| GENENTECH INC | OGR | 1 | $0 | Q3 2026 | Q3 2026 | yes |